Enanta Pharmaceuticals reported $57.21M in Cash and Equivalent for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acorda Therapeutics ACOR:US $ 36.17M 9.55M
Amgen AMGN:US $ 11969M 5339M
Anika Therapeutics ANIK:US $ 90.98M 6.2M
Arrowhead Research ARWR:US $ 184.43M 141.55M
AstraZeneca AZN:LN 7067M 8500M
Biocryst Pharmaceuticals BCRX:US $ 199.6M 10.72M
Biogen BIIB:US $ 1541.8M 200.2M
Bristol Myers Squibb BMY:US $ 13540M 2516M
Clovis Oncology CLVS:US $ 171.95M 58.26M
Enanta Pharmaceuticals ENTA:US $ 57.21M 52.6M
Gilead Sciences GILD:US $ 6837M 1944M
GlaxoSmithKline GSK:LN 3453M 50M
Halozyme Therapeutics HALO:US $ 491.68M 44.72M
Heron Therapeutics HRTX:US $ 159.57M 31.6M
Insmed INSM:US $ 846.56M 81.77M
Intercept Pharmaceuticals ICPT:US $ 428.77M 283.15M
IONIS PHARMACEUT IONS:US $ 1987M 1421.88M
Karyopharm Therapeutics KPTI:US $ 137.4M 3.91M
Ligand Pharmaceuticals LGND:US $ 23.43M 1.57M
Marinus Pharmaceuticals MRNS:US $ 145.1M 32.61M
Neurocrine Biosciences NBIX:US $ 311.1M 56.9M
Novartis NOVN:VX SF 7211M 2094M
Novavax NVAX:US $ 366.24M 128.21M
Ptc Therapeutics PTCT:US $ 189.82M 12.47M
Sarepta Therapeutics SRPT:US $ 1599.11M 98.16M
Vertex Pharmaceuticals VRTX:US $ 6275.7M 212.02M
Vital Therapies VTL:US $ 110.44M 23.27M
YTE INCY:US $ 1999.02M 201.44M